Operator of Turkey’s largest port, Mersin International Port, has successfully completed the issuance of $600 million five-year 144A/RegS bond at a coupon rate of 5.375%, raising significant attention from the international investors.
Paksoy is pleased to announce that the capital markets team led by partner Ömer Çollak, together with associates Pınar Tüzün and Nazlı Tönük Çapan, acted as Turkish law counsel to the joint bookrunners in this transaction. Read more
Share
Related persons
You can contact us for detailed information.

Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
29 September 2025
Paksoy advises Merrill Lynch International on Vakıfbank share sale
Paksoy has advised the sole global coordinator and bookrunner, Merrill Lynch International, on the sale of 1.53% of the shares owned by…
25 September 2025
At Paksoy, we have implemented Legora, an industry-leading Generative AI platform designed for legal professionals, across the firm in all our practices
At Paksoy, we have implemented Legora, an industry-leading Generative AI platform designed for legal professionals, across the firm in all…
23 September 2025
Paksoy has been named “Türkiye Firm of the Year” at the Benchmark Litigation Europe Awards 2025
Paksoy has been named “Türkiye Firm of the Year” at the Benchmark Litigation Europe Awards 2025.
17 September 2025
Paksoy advises Ege Kimya on its recent acquisitions of Venator Materials’ Driers Book of Business and 100% of the shares in Metal Oksit
Ege Kimya is a leading Turkish chemicals company with operations in intermediate chemicals serving both domestic and international markets.…
9 September 2025
Paksoy advises Parsan, a Güriş Holding company listed on Borsa Istanbul, on the merger with Omtaş
Parsan, a Güriş Holding group company listed on Borsa Istanbul and active in integrated steel forging and machining business, has now…
4 September 2025
Paksoy advises Solventum on sale of purification and filtration business to Thermo Fisher
Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to…